Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Revlon Revised Outlook Calls For 3% Top-Line Growth
Jun 28 2004
•
By
The Rose Sheet
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Archive
More from HBW Insight